Injectable hormonal contraceptives: technical and safety aspects.
D000293:Adolescent; D000328:Adult; D000818:Animals; D003271:Contraceptive Agents, Female / Q000008:administration & dosage* / Q000009:adverse effects; D004285:Dogs; D004348:Drug Labeling; D005193:Family Planning Services; D005260:Female; D005298:Fertility / Q000187:drug effects; D000882:Haplorhini; D006801:Humans; D007273:Injections, Intramuscular; D008525:Medroxyprogesterone / Q000009:adverse effects / Q000627:therapeutic use; D008599:Menstruation Disturbances / Q000139:chemically induced; D009369:Neoplasms / Q000139:chemically induced; D009640:Norethindrone / Q000009:adverse effects / Q000627:therapeutic use; D051381:Rats
D003271:Contraceptive Agents, Female; D008525:Medroxyprogesterone; D009640:Norethindrone